Reductive release of ferritin iron: a kinetic assay.
Ferritin iron release, a process of considerable interest in biology and medicine, occurs most readily in the presence of reducing agents. Here is described a kinetic assay for measuring the rate of ferritin iron removal promoted by various reductants. The new procedure uses ferrozine as a chromophoric, high-affinity chelator for the product, Fe(II). The initial rate of iron release is quantified by continuous spectrophotometric measurement of the Fe(ferrozine)2/3+ complex which absorbs maximally at 562 nm. The initial rate of iron mobilization is dependent on reductant concentration, but not on the concentration of the chelating agent, ferrozine. Saturation kinetics are observed for all reductants, including dihydroxyfumarate, cysteine, caffeic acid, ascorbate, and glutathione. Superoxide dismutase greatly inhibits ferritin iron release by ascorbate, but has little or no effect on the reducing action of dihydroxyfumarate, cysteine, caffeic acid, or glutathione. Ferritin iron removal by dihydroxyfumarate was inhibited by various metal ions. This new assay may be used for rapid screening of test compounds for treatment of iron overload and for investigation of the mechanistic aspects of ferritin iron reduction.
Boyer
R F
RF
Department of Chemistry, Hope College, Holland, Michigan 49423.
Grabill
T W
TW
Petrovich
R M
RM
D000818:Animals; D001205:Ascorbic Acid; D005293:Ferritins / Q000032:analysis / Q000378:metabolism*; D005297:Ferrozine; D005650:Fumarates; D066298:In Vitro Techniques; D007501:Iron / Q000032:analysis / Q000378:metabolism*; D007700:Kinetics; D010084:Oxidation-Reduction
D005650:Fumarates; C005998:dihydroxyfumarate; D005297:Ferrozine; D005293:Ferritins; D007501:Iron; D001205:Ascorbic Acid